Convalo Health International, Corp.

Convalo Health International, Corp.

April 20, 2016 09:00 ET

Convalo Health International Announces Launch of Portland Outpatient Facility -- 5th Pod out of Eight Planned in 2016

LOS ANGELES, CALIFORNIA--(Marketwired - April 20, 2016) -


Convalo Health International, Corp. (Convalo) (TSX VENTURE:CXV), a company in the addiction recovery industry in the US, announced it has secured a location for an intensive outpatient (IOP) behavioral health and addiction recovery center in Portland, Oregon. This is the second IOP Convalo has secured this quarter and the first secured outside of California.

Located in the heart of Buckman, Portland, the center boasts over 10,000 square feet of space which can accommodate more than 60 patients. This will be Convalo's largest IOP facility to date.

Convalo is actively improving and furnishing the location and plans to launch as early as June, 2016 - benefiting revenues in Convalo's second fiscal quarter. Along with the Portland IOP facility, Convalo is actively looking to secure a residential, detox and mental health facility, expected no later than the third fiscal quarter.

"This second secured IOP location, in addition to the recently opened San Diego location, underscores Convalo's ability to execute on its plan to open an additional eight facilities by the end of the year. The result will be eight Pods - IOP and Detox facilities - across the nation," said Stampp Corbin, CEO of Convalo.

"The financial impact of the Portland expansion will be reflected in the second quarter financials, beginning June 1, 2016. I am pleased with the operational leadership's progress in completing this transaction and seizing this opportunity. This quarter we have invested in our leadership capabilities, adding several key senior executives as we ramp to a nationwide footprint. With this IOP facility, the executive management team took the first steps toward establishing a national footprint with our first pod located outside of California."

About Convalo

Convalo Health International, operating under the brand name BLVD Centers (, is a leader in the highly fragmented addiction rehabilitation market. Led by a seasoned executive management team with experience in US healthcare, Convalo is well positioned for continued national expansion by launching Pods in cities across the US. A pod consists of a residential, detox, and mental health facility "detox facility" and an intensive outpatient facility "IOP facility". Convalo, under the BLVD brand, is focused on becoming the largest national provider of a range of mental health services, including addictive and co-occurring disorders, helpful to the recovery process. In conjunction with the 12-Step approach, BLVD also offers supplemental insurance-reimbursed services catering to a variety of communities: gender specific, creatively-oriented, meditation/mindfulness, trauma and LGBT affirmative.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

Information in this news release that is not current or historical factual information may constitute forward-looking information within the meaning of securities laws. Implicit in this information, particularly in respect of the future outlook of Convalo and anticipated events or results, are assumptions based on beliefs of Convalo's senior management as well as information currently available to it. While these assumptions were considered reasonable by Convalo at the time of preparation, they may prove to be incorrect. Readers are cautioned that actual results are subject to a number of risks and uncertainties, including the availability of funds and resources to pursue operations, decline of reimbursement rates, dependence on few payors, possible new drug discoveries, a novel business model, dependence on key suppliers, granting of permits and licenses in a highly regulated business, competition, difficulty integrating newly acquired businesses, the outcome and cost of any litigation with the sellers of Hollywood Detox, low profit market segments as well as general economic, market and business conditions, and could differ materially from what is currently expected. These financial measures are intended to provide additional information to investors concerning Convalo's performance.

Contact Information